United States Biotechnology & Medical Research

Rain Therapeutics Inc (RAIN)

Track

Ticker: RAIN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rain Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 18 Dec 2023
Value US$1,667,273.24 | Price 298.94 | Shares 76,796 (+19.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-18 2023-12-18 S Sale
3.3
TANG KEVIN C
Large shareholder
76,796 +19.3%
298.94
US$1,667,273 		76,796 +19.3% 298.94 US$1,667,273
2023-12-18 2023-12-15 S Sale
3.3
TANG KEVIN C
Large shareholder
5,279 +26.0%
184.19
US$429,820 		5,279 +26.0% 184.19 US$429,820
2023-12-18 2023-12-14 S Sale
3.3
TANG KEVIN C
Large shareholder
9,810 +7.7%
17.33
US$352,465 		9,810 +7.7% 17.33 US$352,465
2023-10-13 2023-10-13 B Purchase
3.3
TANG KEVIN C
Large shareholder
84,145 +2.1%
0.99
US$83,304 		84,145 +2.1% 0.99 US$83,304
2023-10-13 2023-10-13 B Purchase
3.3
TANG KEVIN C
Large shareholder
47,486 +1.2%
0.99
US$47,011 		47,486 +1.2% 0.99 US$47,011
2023-10-13 2023-10-12 B Purchase
3.3
TANG KEVIN C
Large shareholder
52,514 +1.4%
0.98
US$51,464 		52,514 +1.4% 0.98 US$51,464
2023-10-13 2023-10-12 B Purchase
3.3
TANG KEVIN C
Large shareholder
25,188 +0.7%
0.98
US$24,684 		25,188 +0.7% 0.98 US$24,684
2023-10-13 2023-10-11 B Purchase
3.3
TANG KEVIN C
Large shareholder
74,812 +2.0%
0.97
US$72,568 		74,812 +2.0% 0.97 US$72,568
2023-06-01 2023-06-01 B Purchase
3.3
TANG KEVIN C
Large shareholder
240,341 +6.9%
1.12
US$269,182 		240,341 +6.9% 1.12 US$269,182
2023-06-01 2023-06-01 B Purchase
3.3
TANG KEVIN C
Large shareholder
92,984 +2.7%
1.09
US$101,353 		92,984 +2.7% 1.09 US$101,353
2023-06-01 2023-05-31 B Purchase
3.3
TANG KEVIN C
Large shareholder
5,000 +0.1%
1.10
US$5,500 		5,000 +0.1% 1.10 US$5,500
2023-06-01 2023-05-31 B Purchase
3.3
TANG KEVIN C
Large shareholder
161,180 +5.0%
1.08
US$174,074 		161,180 +5.0% 1.08 US$174,074
2023-06-01 2023-05-30 B Purchase
3.3
TANG KEVIN C
Large shareholder
5,930 +0.2%
1.06
US$6,286 		5,930 +0.2% 1.06 US$6,286
2023-06-01 2023-05-30 B Purchase
3.3
TANG KEVIN C
Large shareholder
2,016 +0.1%
1.08
US$2,177 		2,016 +0.1% 1.08 US$2,177
2023-06-01 2023-05-30 B Purchase
3.3
TANG KEVIN C
Large shareholder
32,890 +1.0%
1.06
US$34,863 		32,890 +1.0% 1.06 US$34,863
2023-06-01 2023-05-30 B Purchase
3.3
TANG KEVIN C
Large shareholder
200,000 +6.7%
1.00
US$200,000 		200,000 +6.7% 1.00 US$200,000
2023-06-01 2023-05-30 B Purchase
3.3
TANG KEVIN C
Large shareholder
347,932 +13.1%
1.05
US$365,329 		347,932 +13.1% 1.05 US$365,329
2023-05-24 2023-05-22 S Sale
3.6
Boxer Capital, LLC

See remarks.

Non-Executive Director
995,000 -46.3%
1.25
US$1,243,750 		995,000 -46.3% 1.25 US$1,243,750
2023-05-22 2023-05-22 PrS Proposed sale
3.6
Boxer Capital, LLC

Seller's CEO is director of issuer

Non-Executive Director
500,000
9.93
US$4,965,000 		500,000 9.93 US$4,965,000
2023-05-22 2023-05-22 PrS Proposed sale
3.6
Boxer Capital, LLC

Seller's CEO is director of issuer

Non-Executive Director
495,000
9.93
US$4,915,350 		495,000 9.93 US$4,915,350
2022-11-23 2022-11-22 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
77,000 +8.3%
8.27
US$636,790 		77,000 +8.3% 8.27 US$636,790
2022-11-23 2022-11-21 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
45,000 +5.1%
7.80
US$351,000 		45,000 +5.1% 7.80 US$351,000
2022-11-14 2022-11-08 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
42,881 +5.1%
5.83
US$249,996 		42,881 +5.1% 5.83 US$249,996
2022-11-10 2022-11-08 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
54,857 +19.1%
5.83
US$319,816 		54,857 +19.1% 5.83 US$319,816
2022-11-10 2022-11-08 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
685,330 +49.3%
5.83
US$3,995,474 		685,330 +49.3% 5.83 US$3,995,474
2022-11-10 2022-11-08 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
970,171 +51.0%
5.83
US$5,656,097 		970,171 +51.0% 5.83 US$5,656,097
2022-11-08 2022-11-04 B Purchase
3.4
Davis Aaron I.
Non-Executive Director
972,212 +82.7%
5.83
US$5,667,996 		972,212 +82.7% 5.83 US$5,667,996
2022-06-02 2022-06-01 B Purchase
3.4
Vellanki Avanish

Chairman and CEO

Executive Director Large shareholder
25,000 +1.0%
2.29
US$57,250 		25,000 +1.0% 2.29 US$57,250
2022-01-10 2022-01-07 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
14,806 +8.7%
12.00
US$177,672 		14,806 +8.7% 12.00 US$177,672
2022-01-10 2022-01-07 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
226,079 +19.8%
12.00
US$2,712,948 		226,079 +19.8% 12.00 US$2,712,948
2022-01-10 2022-01-07 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
255,500 +17.3%
12.00
US$3,066,000 		255,500 +17.3% 12.00 US$3,066,000
2022-01-10 2022-01-06 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
61,343 +5.7%
12.00
US$736,018 		61,343 +5.7% 12.00 US$736,018
2021-10-13 2021-10-12 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
7,306 -0.3%
13.40
US$97,900 		7,306 -0.3% 13.40 US$97,900
2021-10-13 2021-10-11 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
9,351 -0.4%
13.15
US$122,966 		9,351 -0.4% 13.15 US$122,966
2021-10-13 2021-10-11 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
12,475 -0.5%
12.03
US$150,074 		12,475 -0.5% 12.03 US$150,074
2021-10-13 2021-10-08 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
2,462 -0.1%
13.66
US$33,631 		2,462 -0.1% 13.66 US$33,631
2021-10-13 2021-10-08 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
5,038 -0.2%
12.90
US$64,990 		5,038 -0.2% 12.90 US$64,990
2021-10-13 2021-10-07 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
286 -0.0%
15.05
US$4,304 		286 -0.0% 15.05 US$4,304
2021-10-13 2021-10-07 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
13,082 -0.5%
14.80
US$193,614 		13,082 -0.5% 14.80 US$193,614
2021-05-17 2021-05-13 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director
3,474 +3.9%
14.26
US$49,544 		3,474 +3.9% 14.26 US$49,544
2021-05-17 2021-05-13 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director
22,721 +4.3%
14.26
US$324,036 		22,721 +4.3% 14.26 US$324,036
2021-05-17 2021-05-13 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director
31,805 +4.4%
14.26
US$453,587 		31,805 +4.4% 14.26 US$453,587
2021-04-27 2021-04-27 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
550,000 +27.7%
17.00
US$9,350,000 		550,000 +27.7% 17.00 US$9,350,000
2021-04-27 2021-04-27 B Purchase
3.6
Boxer Capital, LLC
Non-Executive Director Large shareholder
1,025,000 +683.3%
17.00
US$17,425,000 		1,025,000 +683.3% 17.00 US$17,425,000
2021-04-27 2021-04-27 B Purchase
3.4
Davis Aaron I.
Non-Executive Director Large shareholder
1,025,000 +683.3%
17.00
US$17,425,000 		1,025,000 +683.3% 17.00 US$17,425,000
2021-04-27 2021-04-23 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
5,000 +4.2%
15.78
US$78,900 		5,000 +4.2% 15.78 US$78,900
2021-04-27 2021-04-23 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
120,000 +inf%
17.00
US$2,040,000 		120,000 +inf% 17.00 US$2,040,000
2021-04-27 2021-04-23 B Purchase
3.6
Boxer Capital, LLC
Non-Executive Director Large shareholder
125,000 +500.0%
16.27
US$2,033,750 		125,000 +500.0% 16.27 US$2,033,750
2021-04-27 2021-04-23 B Purchase
3.6
Boxer Capital, LLC
Non-Executive Director Large shareholder
25,000 +inf%
15.58
US$389,500 		25,000 +inf% 15.58 US$389,500
2021-04-27 2021-04-23 B Purchase
3.4
Davis Aaron I.
Non-Executive Director Large shareholder
125,000 +500.0%
16.27
US$2,033,750 		125,000 +500.0% 16.27 US$2,033,750
2021-04-27 2021-04-23 B Purchase
3.4
Davis Aaron I.
Non-Executive Director Large shareholder
25,000 +inf%
15.58
US$389,500 		25,000 +inf% 15.58 US$389,500
Explore more

More insider trading research around Rain Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America